Release Date: 23/06/11 17:59 Summary: Sinosteel Decision Won't Impact Padbury Development Price Sensitive: Yes Download Document 154.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%